Insider Transactions in Q4 2022 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
165,000
+29.08%
|
$0
$0.43 P/Share
|
|
Dec 27
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-2.67%
|
$640,000
$64.24 P/Share
|
|
Dec 27
2022
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+9.39%
|
$0
$0.46 P/Share
|
|
Dec 20
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-2.74%
|
$612,000
$68.15 P/Share
|
|
Dec 15
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
55,000
-2.27%
|
$3,630,000
$67.0 P/Share
|
|
Dec 15
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+15.83%
|
$0
$0.43 P/Share
|
|
Dec 12
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,750
-4.69%
|
$879,750
$69.3 P/Share
|
|
Dec 12
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+8.26%
|
$0
$0.46 P/Share
|
|
Dec 12
2022
|
Catherine M. Szyman Director |
SELL
Bona fide gift
|
Direct |
16,000
-50.17%
|
-
|
|
Nov 28
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.32%
|
$740,000
$74.81 P/Share
|
|
Nov 21
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-3.79%
|
$693,000
$77.68 P/Share
|
|
Nov 15
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.22%
|
$560,000
$80.13 P/Share
|
|
Nov 15
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
55,000
-1.47%
|
$4,455,000
$81.61 P/Share
|
|
Nov 14
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,750
-2.89%
|
$1,007,250
$79.19 P/Share
|
|
Nov 14
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+7.65%
|
$0
$0.46 P/Share
|
|
Oct 27
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-2.41%
|
$760,000
$76.21 P/Share
|
|
Oct 20
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-1.77%
|
$648,000
$72.63 P/Share
|
|
Oct 18
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.22%
|
$560,000
$80.07 P/Share
|
|
Oct 17
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
55,000
-1.21%
|
$4,125,000
$75.28 P/Share
|
|
Oct 14
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,750
-1.61%
|
$943,500
$74.76 P/Share
|
|
Oct 14
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+7.12%
|
$0
$0.46 P/Share
|
|
Oct 01
2022
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-0.32%
|
$49,248
$72.64 P/Share
|
|
Oct 01
2022
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-0.38%
|
$71,496
$72.64 P/Share
|
|
Oct 01
2022
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,420
-0.2%
|
$102,240
$72.64 P/Share
|
|
Oct 01
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
663
-0.42%
|
$47,736
$72.64 P/Share
|